Home » Newsletters » BioWorld Science

BioWorld Science

April 23, 2002

View Archived Issues

Cell Therapeutics presents data on metabolism of CT-2103

LErafAON improves tumor chemotherapy effectiveness in preclinical studies

Second-generation cell cycle inhibitors with improved solubility, oral bioavailability

Taxane-based MDR reversal agents presented at AACR meeting

Data presented at AACR meeting demonstrate promise of novel family of antimitotic agents

Targeted drug delivery using A-Z-CINN Linker proved effective in breast cancer model

Dopamine stabilizer to be evaluated in schizophrenic patients

PSP-94 may have an expanded role in prostate cancer, inhibiting metastasis and hypercalcemia

Sulfonamide 5-HT6 antagonist with advantageous pharmacological profile

Synthesis and use of integrin receptor antagonists described by Pharmacia team

Pfizer presents new 5-HT reuptake inhibitors and uses thereof

New series of protein kinase inhibitors useful for cancer, neurodegenerative disorders, etc.

Abbott reveals newly synthesized PTP1B inhibitors

Potent and selective MC4 receptor agonists designed at Roche

Boehringer Ingelheim research focuses on PTK inhibitors

Monoclonal antibody-auristatin E conjugates effective in established tumors

SGN-30, a chimeric anti-CD30 MAb, in the treatment of Hodgkin's disease

MedImmune licenses cancer technologies

Abbott makes tender offer to acquire Hokuriku Seiyaku

Paxil CR launched in U.S.

Cohesion licenses PEG technology to Zycos

Telik extends TRAP collaboration with Sanwa Kagaku

MAA filed for Olux in U.K.

Patient treatment initiated in phase II trial of Aryplase in MPS VI

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...